Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05587790
Other study ID # 22642
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 9, 2022
Est. completion date May 23, 2023

Study information

Verified date May 2024
Source University of Illinois at Urbana-Champaign
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research is to expand a virtual weight loss and weight maintenance program to rural counties of Illinois. The program uses dietary and lifestyle modifications for adults with obesity. The EMPOWER weight loss program has proven to be effective in 3 previous trials. In this research, we target a rural participant population. Individuals in rural locations are more likely to be affected by obesity and have unique barriers to weight loss related to geographic isolation including access to health care, preventative care, grocery stores, social networks, internet, and cell service.


Description:

EMPOWER is a remote weight management program that uses an online textbook platform, E-Text, and mobile web application, MealPlot. This pilot study will test for feasibility of the EMPOWER program in a rural population prior to launching a full-scale study. Acceptability measurements will be applied at 3 months to evaluate for needed changes; Participants of the pilot study will be permitted to continue on with the full program. EMPOWER is a two-year program: 1-year intervention, 1-year follow up. Data is collected via 24-hour record and daily weighing using a Wi-Fi-enabled scale. 24-hour records and daily weights are collected within the program's proprietary MealPlot website. EMPOWER consists of 19 online sessions (45 minutes/each) and 3 individual advising sessions with a nutrition coach.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date May 23, 2023
Est. primary completion date May 15, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - age 18-75 years; - BMI in overweight to above range; - not currently pregnant or lactating; - willing to access Wi-Fi via home or free public Wi-Fi location at least once a week for 45 minutes - access to a working email - willing to weigh daily and provide data either via Bluetooth, Wi-Fi, or manual input - willing to lose 20 lb. or more and maintain a healthy weight for one year thereafter; - Continue daily-weighing for 12-months after the year-long intervention (Daily weigh for a total of 2 years); - fluent in reading and writing English. - live within one of the counties of the covered Extension Education offices: Eastern (Clark, Crawford, Edgar), Northern (Jo Daviess, Stephenson, Winnebago), Western (Macoupin, Christian, Jersey, Montgomery) Exclusion Criteria: - age <18 or >75 years; - severe chronic diseases; - underweight to normal BMI; - currently pregnant; - currently lactating; - failed to commit to daily weighing; - failed to submit 3, 24 hour records; - underwent bariatric surgery or planning on having bariatric surgery within the next year including: Roux-en-Y Gastric Bypass, Sleeve Gastrectomy, Duodenal Jejunal Bypass with Sleeve Gastrectomy, Duodenal Switch, Laparoscopic Adjustable Gastric Banding.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Weight Management Intervention
Participants attend virtual dietary education sessions and over time create a diet plan that satisfies their individual needs. Participants aim to lose 1-2 pounds weekly until a BMI of 25 is reached. Participants are evaluated through daily self-weighing, dietary records, and anthropometric measures of waist and hip circumference, and body composition.

Locations

Country Name City State
United States UIUC Extension Freeport Illinois
United States UIUC Extension Hillsboro Illinois
United States UIUC Extension Marshall Illinois

Sponsors (1)

Lead Sponsor Collaborator
University of Illinois at Urbana-Champaign

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Enrollment Achieving target enrollment 16 3 Months
Primary Retention Successful retention dropout <20% (13/16) 3 Months
Primary Completion of eText Completion of eText (75% completion) 3 Months
Primary Completion of study measures Completion of 80% of study measures (24-hour records, in-person anthropometric testing) 3 Months
Primary Acceptability 4/5 on average for all program components using likert scales (ranging 1-5) of acceptability of each of the individual components (MealPlot, eText, Zoom, Nutrition Coaching) collected via interview. 3 Months
Secondary Weight loss Change in weight 2 Years
Secondary Dietary habits - protein density protein density change from baseline to 24 months. 2 Years
Secondary Dietary Habits - fiber density Fiber density change from baseline to 24 months. 2 Years
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2